X4 Pharmaceuticals (XFOR) Interest Coverage Ratio Growth (1y) (2018 - 2025)
X4 Pharmaceuticals (XFOR) Interest Coverage Ratio Growth (1y) (2018 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-303.06% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
18.06% |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
67.94% |
| 10 |
X4 Pharmaceuticals |
166.63 Mn |
166.63 Mn |
2.20 Mn |
30.06% |
| Date | Value |
|---|
| Dec 31, 2025 |
30.06% |
| Sep 30, 2025 |
14.72% |
| Jun 30, 2025 |
-135.97% |
| Mar 31, 2025 |
78.44% |
| Dec 31, 2024 |
-16.02% |
| Sep 30, 2024 |
14.19% |
| Jun 30, 2024 |
245.37% |
| Mar 31, 2024 |
24.70% |
| Dec 31, 2023 |
40.24% |
| Sep 30, 2023 |
15.87% |
| Jun 30, 2023 |
-0.32% |
| Mar 31, 2023 |
-13.43% |
| Dec 31, 2022 |
28.82% |
| Sep 30, 2022 |
4.73% |
| Jun 30, 2022 |
-6.75% |
| Mar 31, 2022 |
-15.72% |
| Dec 31, 2021 |
-28.10% |
| Sep 30, 2021 |
14.70% |
| Jun 30, 2021 |
1.62% |
| Mar 31, 2021 |
-11.11% |
